Loading...

SAI - Detailed view

PAXLOVID Filmtabl 4x150mg/2x100mg 5 x 6 Stk

Drug

Paxlovid, Filmtabletten
Behandlung von COVID-19
08.03.0. – antivirals

HAM – Human medicine
FILM – Film-coated tablet
S – synthetic products for human use
A – Dispensed once only on prescription by a physician or veterinarian (A)

Z – approved
6/15/2022
4/4/2029

Dosage strength

Paxlovid, Filmtabletten
Behandlung von COVID-19
01
Z – approved

Package

7680687930017
No information made available
A/R – Authorised / referenced 

30 tablet(s)

001
Z – approved

Declaration

Component A)

150 mg nirmatrelvirum
cellulosum microcristallinum
185 mg lactosum monohydricum
carmellosum natricum conexum
silica colloidalis anhydrica
natrii stearylis fumaras
hypromellosum
E 171
macrogolum 400
E 172 (rubrum)
0.99 mg natrium

Component B)

100 mg ritonavirum
copovidonum
silica colloidalis anhydrica
sorbitani lauras
calcii hydrogenophosphas
natrii stearylis fumaras
hypromellosum
E 171
macrogolum 400
macrogolum 3350
hydroxypropylcellulosum
talcum
silica colloidalis anhydrica
polysorbatum 80
0.388 mg natrium

Spezialitätenliste***

SL
-
-
1113.95
None
Yes
10%
No

Authorisation holder

7601001010604
Pfizer AG
Schärenmoosstrasse 99
8052 Zürich (ZH)

Date of revision of the text

6/1/2024

Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.